Medplus Health Services Receives 'Hold' Rating, Despite Strong Long-Term Growth

Medplus Health Services, a midcap retailing company, has recently received a 'Hold' rating from MarketsMOJO. This upgrade is based on the company's healthy long-term growth, with an annual increase of 23.57% in net sales and 21.44% in operating profit. However, the technical trend for the stock is currently sideways, indicating no clear price momentum. One of the key factors contributing to the 'Hold' rating is the company's attractive valuation, with a ROCE of 5.3 and an enterprise value to capital employed ratio of 3.8. This suggests that the stock is trading at a discount compared to its historical valuations. Despite generating a negative return of -16.02% in the past year, the company's profits have increased by 51%, resulting in a PEG ratio of 2.2. However, there are some concerns regarding the company's management efficiency. With a low ROCE of 5.42%, the company's profitability per unit of total capital is low. Additionally, the company's ability to service its debt is weak, with a poor EBIT to interest ratio of 1.29. The company has also underperformed in the last quarter, with a decrease of 12.3% in PAT and a high debt-equity ratio of 0.64 times. Furthermore, 54.17% of the company's promoter shares are pledged, which can put additional downward pressure on the stock prices in falling markets. This may have contributed to the stock's underperformance in the last year, as it has generated negative returns while the market has seen a positive return of 38.66%. In conclusion, while Medplus Health Services has shown promising growth in the long term, there are some concerns regarding its management efficiency and debt servicing capabilities. The 'Hold' rating suggests that investors should closely monitor the stock's performance before making any investment decisions.